for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

Imcd NV

IMCD.AS

前日終値

69.85EUR

変化

-1.10(-1.55%)

出来高

106,269

本日のレンジ

69.05

 - 

70.05

52週レンジ

53.95

 - 

82.75

∙ 約15分前の相場を表示しています。

適時開示

Imcd Acquires Monachem Additives

Sept 18 (Reuters) - IMCD NV <IMCD.AS>::IMCD EXPANDS ITS INDIAN FOOTPRINT BY ACQUIRING MONACHEM ADDITIVES.ACQUISITION IS PAID FROM AVAILABLE CASH AND EXISTING FACILITIES..

IMCD Buys Business Of Food Ingredient Distributor Matrix Ingredients In Singapore, Malaysia

Aug 30 (Reuters) - IMCD NV <IMCD.AS>::IMCD ACQUIRES THE BUSINESS OF FOOD INGREDIENT DISTRIBUTOR MATRIX INGREDIENTS IN SINGAPORE AND MALAYSIA.ACQUISITION IS PAID FROM AVAILABLE CASH AND EXISTING FACILITIES.

IMCD H1 Operating EBITA Up At 123.1 Million Euros

Aug 16 (Reuters) - IMCD NV <IMCD.AS>::REG-IMCD REPORTS 17% EBITA GROWTH IN THE FIRST HALF OF 2019.H1 NET RESULT BEFORE AMORTISATION AND NON-RECURRING ITEMS INCREASE OF 14% TO EUR 84.8 MILLION (+14% ON A CONSTANT CURRENCY BASIS).H1 OPERATING EBITA INCREASE OF 17% TO EUR 123.1 MILLION (+17% ON A CONSTANT CURRENCY BASIS).H1 CASH EARNINGS PER SHARE INCREASED BY 22% TO EUR 1.60 (FIRST HALF OF 2018: EUR 1.31).H1 GROSS PROFIT GROWTH OF 19% TO EUR 312.0 MILLION.IMCD EXPECTS OPERATING EBITA GROWTH IN 2019.AS AT 30 JUNE 2019, NET DEBT WAS EUR 683.6 MILLION COMPARED TO EUR 610.7 MILLION AS AT 31 DECEMBER 2018.SEES INTERESTING OPPORTUNITIES TO INCREASE ITS GLOBAL FOOTPRINT AND EXPAND ITS PRODUCT PORTFOLIO BOTH ORGANICALLY AND BY ACQUISITIONS.CO EXPERIENCED A MUCH MORE CHALLENGING MACRO-ECONOMIC ENVIRONMENT IN THE SECOND QUARTER WHICH IMPACTED GROWTH - CEO.H1 FREE CASH FLOW WAS EUR 80.9 MILLION COMPARED TO EUR 54.0 MILLION IN THE FIRST HALF OF 2018.CURRENT MARKET CONDITIONS ARE VOLATILE AND UNCERTAIN - CEO.

IMCD Reports EBITA Growth Of 28% At 63.7 Million Euros In Q1

May 8 (Reuters) - IMCD NV <IMCD.AS>::REPORTS 28% EBITA GROWTH IN THE FIRST THREE MONTHS OF 2019.Q1 OPERATING EBITA INCREASE OF 28% TO EUR 63.7 MILLION (+27% ON A CONSTANT CURRENCY BASIS).IMCD EXPECTS OPERATING EBITA GROWTH IN 2019.Q1 NET RESULT BEFORE AMORTISATION AND NON-RECURRING ITEMS INCREASE OF 27% TO EUR 44.5 MILLION.IN Q1 FREE CASH FLOW WAS EUR 49.8 MILLION.AS AT 31 MARCH 2019, NET DEBT WAS EUR 653 MILLION COMPARED TO EUR 611 MILLION AT YEAR END 2018..Q1 REVENUE WAS EUR 704.8 MILLION, AN INCREASE OF 24% COMPARED TO THE SAME PERIOD IN 2018.Q1 GROSS PROFIT GROWTH OF 23% TO EUR 157.9 MLN (+23% ON A CONSTANT CURRENCY BASIS).IN Q1 CASH EARNINGS PER SHARE INCREASED BY 25% TO EUR 0.83 (FIRST THREE MONTHS OF 2018: EUR 0.67).

BRIEF-Imcd Expands Distribution Partnership With Dupont Industrial Biosciences

Replaces 'signs' by 'expands':IMCD EXPANDS BIOCIDE OFFERINGS WITH DUPONT INDUSTRIAL BIOSCIENCES IN EUROPE AND SOUTH AFRICA.EXPANSION OF DISTRIBUTION PARTNERSHIP IN EUROPE FOR BIOCIDES USED IN INDUSTRIAL PRESERVATION AND HOMECARE APPLICATIONS, INCLUDING ROCIMA, BIOBAN AND KATHON.

IMCD Reports 25% EBITA Growth In 2018

March 1 (Reuters) - IMCD NV <IMCD.AS>::REG- IMCD REPORTS 25% EBITA GROWTH IN 2018.FY NET RESULT BEFORE AMORTISATION AND NON-RECURRING ITEMS OF EUR 139.7 MILLION (2017: EUR 110.1 MILLION).FY REVENUE GROWTH OF 25% TO EUR 2,379.1 MILLION (+29% ON A CONSTANT CURRENCY BASIS).OPERATING EBITA INCREASED BY 25% TO EUR 202.1 MILLION .DIVIDEND PROPOSAL OF EUR 0.80 IN CASH PER SHARE (2017: EUR 0.62).TO EXPAND ITS PRODUCT PORTFOLIO BOTH ORGANICALLY AND BY ACQUISITIONS.REMAINS FOCUSED ON ACHIEVING EARNINGS GROWTH BY OPTIMISING ITS SERVICES AND FURTHER STRENGTHENING ITS MARKET POSITIONS.

IMCD Completes Acquisition Of Aroma

Nov 14 (Reuters) - IMCD NV <IMCD.AS>::IMCD SUCCESSFULLY COMPLETES ACQUISITION OF INDIAN SPECIALTY CHEMICALS DISTRIBUTOR AROMA.

IMCD 9 Month Operating EBITA Up At 156.6 Million Euros

Nov 7 (Reuters) - IMCD NV <IMCD.AS>::9MTH GROSS PROFIT GROWTH OF 25% TO EUR 398.7 MILLION (+30% ON A CONSTANT CURRENCY BASIS).9MTH OPERATING EBITA INCREASE OF 26% TO EUR 156.6 MILLION (+32% ON A CONSTANT CURRENCY BASIS).9MTH NET RESULT BEFORE AMORTISATION AND NON-RECURRING ITEMS INCREASE OF 28% TO EUR 109.2 MILLION (+33% ON A CONSTANT CURRENCY BASIS).CASH EARNINGS PER SHARE INCREASED BY 23% TO EUR 1.97.9MTH REVENUE EUR 1.75 BILLION VERSUS EUR 1.41 BILLION YEAR AGO.EXPECTS OPERATING EBITA GROWTH IN 2018..

IMCD US Pharma Expands With Dupont In United States Nutra Market

Oct 23 (Reuters) - IMCD NV <IMCD.AS>::IMCD US PHARMA EXPANDS WITH DUPONT IN US NUTRA MARKET.

IMCD H1 EBITA Up 24% Y\Y

Aug 17 (Reuters) - IMCD NV <IMCD.AS>::REG-IMCD REPORTS 24% EBITA GROWTH IN THE FIRST HALF OF 2018.SAYS H1 OPERATING EBITA INCREASE OF 24% TO EUR 105.2 MILLION (+30% ON A CONSTANT CURRENCY BASIS).SAYS H1 GROSS PROFIT GROWTH OF 24% TO EUR 263.1 MILLION (+30% ON A CONSTANT CURRENCY BASIS).SAYS H1 NET RESULT BEFORE AMORTISATION AND NON-RECURRING ITEMS INCREASE OF 28% TO EUR 74.2 MILLION (+34% ON A CONSTANT CURRENCY BASIS).H1 REVENUE INCREASED FROM EUR 936.2 MILLION TO EUR 1,151.8 MILLION.SAYS EXPECTS OPERATING EBITA GROWTH IN 2018.

金融情報はリフィニティブから。すべての情報は少なくとも15分遅れで表示されています。

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up